Clinical Trial Update: The Effect of Alga Dunaliella Bardawil on Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Dunaliella bardawil algae extract for psoriasis; the current status of the study is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Dunaliella bardawil extract (Dunaliella bardawil extract)

Snippet

Sponsor: Sheba Medical Center | Conditions: Psoriasis | Phase 3 | Status: UNKNOWN